In vivo siRNA delivery to tumor cells and its application to cancer gene therapy

Yakugaku Zasshi

Volumn 127, Issue 10, 2007, Pages 1525-1531

  Takahashi, Yuki ^a   Nishikawa, Makiya ^a   Takakura, Yoshinobu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Electroporation; Hydrodynamic delivery; RNA interference; Short hairpin RNA; Tumor growth

Indexed keywords

BETA CATENIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LUCIFERASE; MESSENGER RNA; PLASMID DNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

AREA UNDER THE CURVE; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER INHIBITION; ELECTROPORATION; GENE SILENCING; GENE TARGETING; HYDRODYNAMICS BASED TRANSFECTION; MEAN RESIDENCE TIME; NONHUMAN; REPORTER GENE; REVIEW; RNA INTERFERENCE;

ANIMALS; ELECTROCHEMOTHERAPY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 34848865295     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.127.1525     Document Type: Review

References (26)

1. Fire A., Xu S., Montgomery M. K., Kostas S. A., Driver S. E., Mello C. C., Nature, 391, 806-811 (1998).
2. Zamore P. D., Tuschl T., Sharp P. A., Bartel D. P., Cell, 101, 25-33 (2000).
3. Tuschl T., Zamore P. D., Lehmann R., Bartel D. P., Sharp P. A., Genes Dev., 13, 3191-3197 (1999).
4. Gong H., Liu C. M., Liu D. P., Liang C. C., Med. Res. Rev., 25, 361-381 (2005).
5. Rye P. D., Stigbrand T., Tumour Biol., 25, 329-336 (2004).
6. Zeng Y., Cullen B. R., RNA, 8, 855-860 (2002).
7. Braasch D. A., Liu Y., Corey D. R., Biochemistry, 42, 7967-7975 (2003).
8. Xia H., Mao Q., Paulson H. L., Davidson B. L., Nat. Biotechnol., 20, 1006-1010 (2002).
9. Miyagishi M., Taira K., Nat. Biotechnol., 20, 497-500 (2002).
10. Marshall E., Science, 287, 565-567 (2000).
11. Marshall E., Science, 286, 2224-2245 (1999).
12. Marshall E., Science, 298, 34-35 (2002).
13. Nishikawa M., Huang L., Hum. Gene Ther., 12, 861-870 (2001).
14. Takahashi Y., Nishikawa M., Kobayashi N., Takakura Y., J. Control. Release, 105, 332-343 (2005).
15. Takahashi Y., Yamaoka K., Nishikawa M., Takakura Y., Biotechnol. Bioeng., 93, 816-819 (2006).
16. Sakai M., Nishikawa M., Thanaketpaisarn O., Yamashita F., Hashida M., Gene Ther., 12, 607-616 (2005).
17. McCaffrey A. P., Meuse L., Pham T.-T. T., Conklin D. S., Hannon G. J., Kay M. A., Nature, 418, 38-39 (2002).
18. Hirata K., Nishikawa M., Kobayashi N., Takahashi Y., Takakura Y., J. Pharm. Sci., 96, 2251-2261 (2007).
19. Kobayashi N., Kuramoto T., Yamaoka K., Hashida M., Takakura Y., J. Pharmacol. Exp. Ther., 297, 853-860 (2001).
20. Takahashi Y., Nishikawa M., Takakura Y., J. Control. Release, 116, 90-95 (2006).
21. Kim W. J., Christensen L. V., Jo S., Yockman J. W., Jeong J. H., Kim Y.-H., Kim S. W., Mol. Ther., 14, 343-350 (2006).
22. Chae S. S., Paik J. H., Furneaux H., Hla T., J. Clin. Invest., 114, 1082-1089 (2004).
23. Mook O. R., Baas F., Wissel M. B., Fluiter K., Mol. Cancer Ther., 6, 833-843 (2007).
24. Duxbury M. S., Ito H., Zinner M. J., Ashley S. W., Whang E. E., Oncogene, 23, 1448-1456 (2004).
25. Pal A., Ahmad A., Khan S., Sakabe I., Zhang C., Kasid U. N., Ahmad I., Int. J. Oncol., 26, 1087-1091 (2005).
26. Santel A., Aleku M., Keil O., Endruschat J., Esche V., Durieux B., Löffler K., Fechtner M., Röhl T., Fisch G., Dames S., Arnold W., Giese K., Klippel A., Kaufmann J., Gene Ther., 13, 1360-1370 (2006).